Speaker Profile
Ph.D., Chief Scientific Officer, Karkinos
Biography
Dr. Prashant Kumar brings along with him vast expertise accomplishments in the field of Cancer Biology and has done extensive research to enhance the translational merits of cancer research. He worked in several pathbreaking research initiatives that includes establishing a novel mouse model of malignant breast cancers, optimization of a culture method to assess CTCs, implementation of cuttingedge technologies in genomics, proteomics to investigate biomarkers and therapeutic targets to accelerated discovery in the advancement towards cancer vaccines, precision medicine, molecular diagnostics.Dr. Kumar received his Ph.D. in 2009 from the Max Planck Institute for Infection Biology, Berlin, Germany. Following this, he did his postdoctoral work at the Department of Cancer Biology, UMASS, Worcester, USA. To further advance his research stint, he joined Prof. JeanPaul Thiery, a world renowned authority in the area of EMT at IMCB, ASTAR Singapore. Currently he is the Chief Scientific Officer (CSO) of Karkinos Healthcare.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Stacey Gabriel, Broad Institute and Steve Turner, PacBio
- New Frontiers in Genomic Analysis & Interpretation (PANEL)
- Robert Sebra, ISMMS - From Potential to Reality: Bringing Nanopore Sequencing to Clinical Practice (PANEL)
Chair: Emma Stanton, Oxford Nanopore Tech - Population Sequencing at Scale: Impact and Future Path of Genomic Programs (PANEL)
Chair: Stacey Gabriel, Broad Institute
- Heidi Rehm, MGH
- Cindy Lawley, Olink
- John M. Gaziano, Million Veterans Program (MVP) - The Economic Perspective on Genomics (PANEL)
Chair: Paul Spellman, UCLA
- Walter Kowtoniuk, Third Rock Ventures - Building Bridges: Precision Medicine Communities
- Kumar Prashant, Karkinos
